BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7559193)

  • 21. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine.
    Schoondermark-van de Ven E; Galama J; Vree T; Camps W; Baars I; Eskes T; Meuwissen J; Melchers W
    Antimicrob Agents Chemother; 1995 Jan; 39(1):137-44. PubMed ID: 7695295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii.
    Gross U; Pohl F
    Curr Top Microbiol Immunol; 1996; 219():235-45. PubMed ID: 8791704
    [No Abstract]   [Full Text] [Related]  

  • 24. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
    Araujo FG; Lin T; Remington JS
    J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro effects of sulfadiazine and its metabolites alone and in combination with pyrimethamine on Toxoplasma gondii.
    Schoondermark-van de Ven E; Vree T; Melchers W; Camps W; Galama J
    Antimicrob Agents Chemother; 1995 Mar; 39(3):763-5. PubMed ID: 7793889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
    Alder J; Hutch T; Meulbroek JA; Clement JC
    J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1141-8. PubMed ID: 7932081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
    Khan AA; Lambert LH; Remington JS; Araujo FG
    Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
    J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
    Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures.
    Sheffield HG; Melton ML
    J Parasitol; 1975 Aug; 61(4):704-12. PubMed ID: 1165554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of therapeutic effect of colchicine on murine toxoplasmosis.
    Aguirre-Cruz L; Sotelo J
    J Parasitol; 1998 Feb; 84(1):163-4. PubMed ID: 9488356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
    Martinez A; Allegra CJ; Kovacs JA
    Am J Trop Med Hyg; 1996 Mar; 54(3):249-52. PubMed ID: 8600759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG; Shepard RM; Remington JS
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
    Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
    Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
    Mahmoud MS
    J Egypt Soc Parasitol; 1999; 29(3):791-803. PubMed ID: 12561919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
    Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
    Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine.
    Sina S; Mohammad JM; Reza S; Anita M; Soudabeh E; Hadi M
    Eur J Med Res; 2021 Jun; 26(1):65. PubMed ID: 34193287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.
    Luft BJ
    Eur J Clin Microbiol; 1987 Aug; 6(4):479-81. PubMed ID: 3665901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii].
    Braz LM; Di Pietro AO; Amato Neto V; França FO
    Rev Soc Bras Med Trop; 1999; 32(4):401-3. PubMed ID: 10495670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.
    de Oliveira TC; Silva DA; Rostkowska C; Béla SR; Ferro EA; Magalhães PM; Mineo JR
    Exp Parasitol; 2009 Jul; 122(3):233-41. PubMed ID: 19389400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.